A detailed history of Syon Capital LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Syon Capital LLC holds 11,647 shares of BMY stock, worth $684,610. This represents 0.05% of its overall portfolio holdings.

Number of Shares
11,647
Previous 10,240 13.74%
Holding current value
$684,610
Previous $425 Million 41.7%
% of portfolio
0.05%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$39.66 - $51.75 $55,801 - $72,812
1,407 Added 13.74%
11,647 $603 Million
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $501,555 - $660,308
-12,461 Reduced 54.89%
10,240 $425 Million
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $445,062 - $504,614
9,276 Added 69.09%
22,701 $1.23 Billion
Q4 2023

Feb 02, 2024

BUY
$48.48 - $57.85 $318,659 - $380,248
6,573 Added 95.93%
13,425 $689 Million
Q3 2023

Nov 03, 2023

BUY
$57.89 - $64.73 $396,662 - $443,529
6,852 New
6,852 $398 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Syon Capital LLC Portfolio

Follow Syon Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syon Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Syon Capital LLC with notifications on news.